Thang H. Nguyen

Array ( [id] => 9657235 [patent_doc_number] => 20140228240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'Screening Blood for Protein Biomarkers and Uses Thereof in Alzheimer\'s Disease and Mild Cognitive Impairment' [patent_app_type] => utility [patent_app_number] => 14/180844 [patent_app_country] => US [patent_app_date] => 2014-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19744 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14180844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10693769 [patent_doc_number] => 20160039916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'TRANSTHYRETIN ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/760194 [patent_app_country] => US [patent_app_date] => 2014-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 34352 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14760194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10938890 [patent_doc_number] => 20140341911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'Prevention and Treatment of Amyloidogenic Disease' [patent_app_type] => utility [patent_app_number] => 14/146700 [patent_app_country] => US [patent_app_date] => 2014-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32208 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14146700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9465765 [patent_doc_number] => 20140130192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'Nucleic Acid Encoding a Brain Derived Tau Kinase Polypeptide and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 14/144708 [patent_app_country] => US [patent_app_date] => 2013-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21675 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14144708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10435849 [patent_doc_number] => 20150320861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-12 [patent_title] => 'EGFR TARGETED THERAPY OF NEUROLOGICAL DISORDERS AND PAIN' [patent_app_type] => utility [patent_app_number] => 14/654180 [patent_app_country] => US [patent_app_date] => 2013-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17088 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9448868 [patent_doc_number] => 20140120037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'METHOD FOR DETECTION OF AMYLOIDS BETA OLIGOMERS IN A FLUID SAMPLE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/137351 [patent_app_country] => US [patent_app_date] => 2013-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13138 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14137351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16415856 [patent_doc_number] => 10823739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => Immunoassay standards and measurement of tau using intra-assay calibration standards [patent_app_type] => utility [patent_app_number] => 14/652584 [patent_app_country] => US [patent_app_date] => 2013-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 8564 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14652584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10987451 [patent_doc_number] => 20160184397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF DISEASE INVOLVING ABNORMAL ACCUMULATION OF AMYLOID BETA PROTEIN' [patent_app_type] => utility [patent_app_number] => 14/653442 [patent_app_country] => US [patent_app_date] => 2013-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4365 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10435848 [patent_doc_number] => 20150320860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-12 [patent_title] => 'METHOD FOR TREATING A DISEASE ASSOCIATED WITH SOLUBLE, OLIGOMERIC SPECIES OF AMYLOID BETA 1-42' [patent_app_type] => utility [patent_app_number] => 14/648316 [patent_app_country] => US [patent_app_date] => 2013-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 26888 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9517788 [patent_doc_number] => 20140154280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'FUSION PROTEINS FOR USE AS IMMUNOGENIC ENHANCERS FOR INDUCING ANTIGEN-SPECIFIC T CELL RESPONSES' [patent_app_type] => utility [patent_app_number] => 14/095947 [patent_app_country] => US [patent_app_date] => 2013-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6076 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14095947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9602641 [patent_doc_number] => 20140199323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'Monoclonal Antibody' [patent_app_type] => utility [patent_app_number] => 14/077915 [patent_app_country] => US [patent_app_date] => 2013-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 32988 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14077915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10380673 [patent_doc_number] => 20150265680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 14/437459 [patent_app_country] => US [patent_app_date] => 2013-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13745 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9421239 [patent_doc_number] => 20140105890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'HUMANIZED ANTIBODIES SPECIFIC TO THE PROTOFIBRILLAR FORM OF THE BETA-AMYLOID PEPTIDE' [patent_app_type] => utility [patent_app_number] => 14/042942 [patent_app_country] => US [patent_app_date] => 2013-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6229 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14042942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9306051 [patent_doc_number] => 20140044725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'ALZHEIMER\'S DISEASE TREATMENT METHOD' [patent_app_type] => utility [patent_app_number] => 14/026374 [patent_app_country] => US [patent_app_date] => 2013-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3823 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14026374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11250375 [patent_doc_number] => 09475866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-25 [patent_title] => 'Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/427575 [patent_app_country] => US [patent_app_date] => 2013-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 12 [patent_no_of_words] => 47921 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9656269 [patent_doc_number] => 20140227274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'Prevention and Treatment of Amyloidogenic Disease' [patent_app_type] => utility [patent_app_number] => 14/017177 [patent_app_country] => US [patent_app_date] => 2013-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32242 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14017177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10181668 [patent_doc_number] => 09211330 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-15 [patent_title] => 'A-beta binding polypeptides' [patent_app_type] => utility [patent_app_number] => 14/013364 [patent_app_country] => US [patent_app_date] => 2013-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 37020 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14013364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9338854 [patent_doc_number] => 20140065636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'METHODS FOR MEASURING CONCENTRATIONS OF BIOMOLECULES' [patent_app_type] => utility [patent_app_number] => 13/967816 [patent_app_country] => US [patent_app_date] => 2013-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11290 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11805953 [patent_doc_number] => 09547010 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-17 [patent_title] => 'Anti-idiotype antibody against an antibody against the amyloid β peptide' [patent_app_type] => utility [patent_app_number] => 13/960893 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7544 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9338941 [patent_doc_number] => 20140065723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'ENRICHMENT AND PURIFICATION OF INFECTIOUS PRION PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/949905 [patent_app_country] => US [patent_app_date] => 2013-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7647 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13949905 [rel_patent_id] =>[rel_patent_doc_number] =>)